UCB Data Shows Comparable Performance of Clones Cultured in ambr and 100L Bioreactors Indicating TAP Biosystems’ Micro Bioreactor is a Realistic Scale-down Model for Cell line Selection
TAP Biosystems
10/04/2013Cambridge, UK: TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, today announced that new data presented at a Cell Line Development and Engineering meeting by scientists at major European biopharmaceutical firm, UCB has shown that the micro-scale bioreactor system (ambr™) is equivalent in performance to a 100L bioreactor. This indicates that ambr is a realistic scale-down model and can be used to...